Cempra Inc
(CEMP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CEMP | PRLD | IKT | ||
| Company | Cempra Inc | Prelude Therapeutics Inc | Inhibikase Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.25 | 1.9900 | 1.5900 | ||
| High | 2.35 | 2.0503 | 1.6000 | ||
| Low | 2.20 | 1.8000 | 1.5500 | ||
| Latest | 2.33 | 1.9000 | 1.5700 | ||
| Change | +0.03 | -0.0700 | -0.0200 | ||
| % Change | +1.30% | -3.55% | -1.26% | ||
| Volume | 511,600 | 894,800 | 327,500 | ||
| 20-Day Average Volume | 743,305 | 494,765 | 511,430 | ||
| Previous Close | 2.30 | 1.9700 | 1.5900 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.70 | 2.2710 | 1.7567 | ||
| 20-Day Raw Stochastic | 23.33% | 11.02% | 3.28% | ||
| 20-Day Relative Strength | 32.74 | 46.83 | 44.58 | ||
| Weighted Alpha | -52.60 | +27.65 | -30.48 | ||
| Today's Opinion | N/A | 56% Buy | 32% Sell | ||
| Previous Opinion | N/A | 56% Buy | 32% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.65% since 10/27/17 | -14.03% since 01/22/26 | -12.78% since 01/22/26 | ||
| Low | 2.10 on 10/30/17 | 1.8000 on 01/29/26 | 1.5500 on 01/29/26 | ||
| High | 2.45 on 11/01/17 | 2.2100 on 01/23/26 | 1.8500 on 01/23/26 | ||
| 1-Month | |||||
| %Chg | -29.39% since 10/03/17 | -35.37% since 12/29/25 | -19.90% since 12/29/25 | ||
| Low | 2.05 on 10/27/17 | 1.7650 on 01/20/26 | 1.5500 on 01/29/26 | ||
| High | 3.40 on 10/04/17 | 2.9900 on 01/08/26 | 2.1591 on 01/05/26 | ||
| 3-Month | |||||
| %Chg | -39.48% since 08/03/17 | +20.25% since 10/29/25 | +9.79% since 10/29/25 | ||
| Low | 2.05 on 10/27/17 | 1.1730 on 11/10/25 | 1.3300 on 11/03/25 | ||
| High | 4.40 on 08/09/17 | 4.2200 on 11/03/25 | 2.1591 on 01/05/26 | ||
| 6-Month | |||||
| %Chg | -39.48% since 05/03/17 | +128.45% since 07/29/25 | -7.65% since 07/29/25 | ||
| Low | 2.05 on 10/27/17 | 0.7500 on 08/12/25 | 1.3300 on 11/03/25 | ||
| High | 4.85 on 07/05/17 | 4.2200 on 11/03/25 | 2.1591 on 01/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 122,086 | 123,844 | 119,528 | ||
| Shares Outstanding, K | 52,510 | 62,865 | 75,175 | ||
| Annual Sales | 18,020,000 | 7,000,000 | 0 | ||
| Annual Net Income | -117,960,000 | -127,170,000 | -27,520,000 | ||
| Last Quarter Sales | 860,000 | 6,500,000 | 0 | ||
| Last Quarter Net Income | -12,270,000 | -19,730,000 | -11,930,000 | ||
| 60-Month Beta | 0.99 | 0.90 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 08/09/17 | -0.26 on 11/12/25 | -0.13 on 11/14/25 | ||
| Latest Earnings Date | 11/09/17 | 03/09/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||